Viewing Study NCT00003560

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:13 AM
Ignite Modification Date: 2026-01-25 @ 3:09 AM
Study NCT ID: NCT00003560
Status: UNKNOWN
Last Update Posted: 2014-01-06
First Post: 1999-11-01
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Sponsor: Herbert Irving Comprehensive Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Endometrial Cancer View
None Fallopian Tube Cancer View
None Ovarian Cancer View
None Primary Peritoneal Cavity Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage III ovarian epithelial cancer View
None stage IV ovarian epithelial cancer View
None stage III endometrial carcinoma View
None stage IV endometrial carcinoma View
None endometrial papillary serous carcinoma View
None fallopian tube cancer View
None primary peritoneal cavity cancer View